FOXO4-DRI vs Epitalon vs NAD+
Mechanism, receptor target, half-life, dose, and best-price vendor side by side.
Pick 2–3 peptides to compare
3 selected (maximum).
| Field | FOXO4-DRI | Epitalon | NAD+ |
|---|---|---|---|
| Receptor target | FOXO4 / p53 interaction (senolytic) | Telomerase activation (pineal-targeted) | NAD+ cofactor (sirtuin, PARP, CD38 substrate) |
| Mechanism class | longevity | longevity | longevity |
| Half-life | ~2 hours | ~20–30 minutes | — |
| Typical dose | 1–5 mg 3x weekly SC (research) | 5–10 mg daily SC (cycled) | 100–300 mg daily IV/SC |
| Sequence length | — | 4 residues | — |
| Best-price vendor | Glacier Aminos → $101.24 (10mg) — $10.12/mg | Swiss Chems → $23.16 (10mg) — $2.32/mg | Glacier Aminos → $86.24 (1500mg) — $0.06/mg |
| See all vendors | /best/foxo4-dri → | /best/epitalon → | /best/nad → |
Dig deeper
Pricing pulls live from our vendor database. Molecular data comes from published peptide literature. For full dosing protocols, side effects, and research citations, open each peptide's individual page.